Loss of ELISA specificity due to biotinylation of monoclonal antibodies

Journal of Immunological Methods

Volumn 235, Issue 1-2, 2000, Pages 91-99

  Høyer Hansen, Gunilla ^a   Hamers, Maria J A G ^a   Pedersen, Anders N ^a   Nielsen, Hans Jørgen ^b   Brünner, Nils ^a   Danø, Keld ^a   Stephens, Ross W ^a  

^a FINSEN LABORATORY   (Denmark)

^b HVIDOVRE HOSPITAL   (Denmark)

Author keywords

Biotinylated antibodies; Biotinylation ratio; ELISA specificity; Surface plasmon resonance

Indexed keywords

MONOCLONAL ANTIBODY; PLASMA PROTEIN;

ARTICLE; BIOTINYLATION; BLOOD SAMPLING; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOASSAY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SURFACE PLASMON RESONANCE;

ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; BIOTINYLATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; RECEPTORS, CELL SURFACE; SURFACE PLASMON RESONANCE;

EID: 0033954827     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-1759(99)00222-7     Document Type: Article

References (15)

1. Behrendt N., Stephens R.W. The urokinase receptor. Fibrinolysis Proteolysis. 12:1998;191.
2. Dale G.L., Gaddy P., Pikul F.J. Antibodies against biotinylated proteins are present in normal human serum. J. Lab. Clin. Med. 123:1994;365.
3. Ghose T.L., Blair A.H., Kulkarni P.N. Preparation of antibody-linked cytotoxic agents. Methods Enzymol. 93:1983;280.
4. Guesdon J.L., Ternunck T., Avrameas S. The use of avidin-biotin interaction in immunoenzymatic techniques. J. Histochem. Cytochem. 27:1979;1131.
5. Harlow, E., Lane, D., 1988. Antibodies: A Laboratory Manual. Cold Spring Harbor Laboratory, New York, p. 341.
6. Mustjoki S., Alitalo R., Stephens R.W., Vaheri A. Blast cell-surface and plasma soluble urokinase plasminogen activator receptor in acute leukemia patients: relationship to classification and response to therapy. Thromb. Haemostasis. 81:1999;705.
7. O'Shannesy D.J., Quarles R.H. Labeling of the oligosaccharide moieties of immunoglobulins. J. Immunol. Methods. 99:1987;153.
8. Pearson J.E., Kane J.W., Petraki-Kallioti I., Gill A., Vadgama P. Surface plasmon resonance: a study of the effect of biotinylation on the selection of antibodies for use in immunoassays. J. Immunol. Methods. 221:1998;87.
9. Piironen T., Løvgren J., Karp M., Eerola R., Lundvall A., Dowell B., Løvgren T., Lilja M., Pettersson K. Immunofluorometric assay for sensitive and specific measurement of human prostatic glandular Kallekrein (hK2) in serum. Clin. Chem. 42:1996;1034.
10. Rønne E., Behrendt N., Ploug M., Nielsen H.J., Wollisch E., Weidle U., Danø K., Høyer-Hansen G. Quantitation of the receptor for urokinase plasminogen activator by enzyme-linked immunosorbent assay. J. Immunol. Methods. 167:1994;91.
11. Rønne E., Pappot H., Grøndahl-Hansen J., Høyer-Hansen G., Plesner T., Hansen N.E., Danø K. The receptor for urokinase plasminogen activator is present in plasma from healthy donors and elevated in patients with paroxysmal nocturnal haemoglobinuria. Br. J. Haematol. 89:1995;576.
12. Sier C.F.M., Stephens R.W., Bizik J., Mariani A., Bassan M., Pedersen N., Frigerio L., Ferrari A., Danø K., Brünner N., Blasi F. The level of urokinase plasminogen activator receptor (uPAR) is increased in serum of ovarian cancer patients. Cancer Res. 58:1998;1843.
13. Slot O., Brünner N., Locht H., Oxholm P., Stephens R.W. Soluble urokinase plasminogen activator receptor in plasma of patients with inflammatory rheumatic disorders: increased concentrations in rheumatoid arthritis. Ann. Rheum. Dis. 58:1999;488.
14. Stephens R.W., Nielsen H.J., Christensen I.J., Thorlacius-Ussing O., Sørensen S., Danø K., Brünner N. Plasma urokinase receptor levels in patients with colorectal cancer: relationship to prognosis. J. Natl. Cancer Inst. 91:1999;869.
15. Stephens R.W., Pedersen A.N., Nielsen H.J., Hamers M.J., Høyer-Hansen G., Rønne E., Dybkjær E., Danø K., Brünner N. ELISA determination of soluble urokinase receptor in blood from healthy donors and cancer patients. Clin. Chem. 43:1997;1868.